Clinical Trial Update: Arsenic Trioxide in Treating Men With Germ Cell Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating arsenic trioxide for men with extragonadal and testicular germ cell tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extragonadal Germ Cell Tumor
• Testicular Germ Cell Tumor

Drugs mentioned

• Arsenic Trioxide (arsenic trioxide)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Extragonadal Germ Cell Tumor, Testicular Germ Cell Tumor | Phase 2 | Status: COMPLETED